Skip to main content
NCBI home page
Mycology logoLink to Mycology
. 2019 Apr 22;10(4):191–209. doi: 10.1080/21501203.2019.1604576

Overview on antibacterial metabolites from terrestrial Aspergillus spp

Abdulkawi Ali Al-Fakih a,✉, Wael Qasem Abdulgabbar Almaqtri b
PMCID: PMC6781474  PMID: 31632829

ABSTRACT

Medicines developed from natural sources are a frequent target for the research and discovery of antimicrobial compounds. Discovering of penicillin in 1928 was a motive to explore of nature as a source of new antimicrobial agents. Fungi produce a diverse range of bioactive metabolites, making them rich source of different types of medicines. The purpose of this paper was to review studies on antibacterials from terrestrial Aspergillus published exclusively during 1942–2018, with emphasis on their antibacterial activities, structures, and mechanisms of action if present. According to the results from different studies in the world, large number of compounds and extracts showed different activities against different bacterial species, including Gram-positive and Gram-negative bacteria. The most prominent result was that of the compound CJ-17,665, isolated from A. ochraceus, showing good activity against multi-drug resistant Staphylococcus aureus, which is well-recognised to be one of the most important current public health problem. These findings may motivate scientists to undertake a project that may result in the development of novel antibacterial drugs from terrestrial-derived Aspergillus spp., although further toxicity assays (in vivo) must be performed before their application.

KEYWORDS: Aspergillus, terrestrial, antibacterial, extracts, metabolites

1. Introduction

Fungi represent one of humanity’s oldest domesticated organisms and are responsible for the production of some of industrial (e.g. alcohol), nutritious (e.g. bread), and medically useful (e.g. penicillin) products (Kavanagh 2011). From the beginning until now, the humankind has always been faced with a problem of spreading of bacterial infections. The kingdom fungi (Mycetae) is well-known as a valuable source of diverse bioactive compounds of therapeutic importance since the discovery of penicillin in 1928 by Alexander Fleming (Fleming 1929; Clutterbuck et al. 1932) from Penicillium notatum. The treatment of bacterial infections is increasingly complicated by the ability of bacteria to develop resistance to antibacterial agents (Levy and Marshall 2004). Therefore, an urgent need to exploit new classes of antibacterial agents with a novel mechanism of action is required. The increasing need for new antibacterial agents able to control emerging diseases or resistant strains of bacteria inspired a number of research groups to explore the terrestrial and marine environments for new antibacterial compounds (Ng et al. 2015). Filamentous fungi represent an important group of microorganisms known to synthesise a vast diversity of bioactive molecules that are traditionally termed secondary metabolites or natural products (Calvo et al. 2002; Horgan and Murphy 2011; Jansen et al. 2013; Bills and Stadler 2014). Secondary metabolites are biologically active organic compounds that are not required for normal growth, development, or reproduction, but provide a competitive advantage to the producing organism. Secondary metabolites are used as medicines, flavourings, pigments, and recreational drugs (Craney et al. 2013). The discovery of penicillin was a real revolution in medicine and the research interest to explore new antibacterial agents from microorganisms is continued. Many intensive studies, mainly on terrestrial-derived and marine-derived fungi, displayed that fungi are a rich source of unique bioactive substances. A large number of antibacterial metabolites are identified in many species of fungi throughout the world and some have been approved as drugs, such as cephalosporins and fusidic acid (Newton and Abraham 1955; Wo et al. 1962). Most fungi-derived pharmaceuticals have been sourced from Ascomyceteous fungi, such as Aspergillus, Penicillium, and so on, whereas perhaps fewer pharmaceuticals, certainly in an industrial context, have been derived from Basidiomycetous fungi and others (Bala et al. 2011). However, more than 30% of isolated metabolites from fungi are from Aspergillus and Penicillium (Bérdy 2005).

Aspergillus species were the most diverse and common fungal species found in the environment. One explanation for the high number of compounds reported from this genus is that Aspergillus spp. are salt tolerant, fast growing species, and are easily obtained from many substrates (Bugni and Ireland 2004). Secondary metabolites isolated from species of the genus Aspergillus have continually attracted the interest of pharmacologists due to their broad array of biological activities and their structural diversity (Cai et al. 2011; Wang et al. 2017). Aspergillus have proven to be a prolific source of secondary metabolites with interesting biological activities, including antibacterial activity (Perrone et al. 2007; Xu et al. 2015). The aim of this review is to present the antibacterial metabolites or extracts described from terrestrial Aspergillus spp., which may have pharmaceutical importance as antibacterial agents. In this review, it is noticed that antibacterial compounds were presented in chronological order. In addition, it is worth mentioning that we have collected all relevant information as far as we can.

2. Assessment techniques of antibacterial activity of fungal metabolites

To assess the antibacterial activity of fungal extracts or pure compounds, several bioassays are well known and commonly used, such as agar disc diffusion method, agar well diffusion method, microdilution method, and a method with incorporation of the extract in the culture medium and determination of bacterial colonies. Thus, the results of antibacterial activity are expressed in different units. In agar disc diffusion method, the extract is incorporated into discs at different concentrations. The clear or inhibition zone developed around each disc was measured and the antibacterial activity is represented by inhibition zone diameter (IZD) (CLSI 2012). The principle of the agar well diffusion method is the same as that of the agar disc diffusion method, but the extract, in fixed volumes, is placed in wells rather than discs (Valgas et al. 2007). Microdilution method comprises microdilutions of the extract in liquid medium using microplates to determine the values of minimal inhibitory concentration (MIC), minimum bactericidal concentration (MBC), which also known as the minimum lethal concentration (MLC), or a concentration that inhibit 50% of the bacterial growth (IC50) (Soothill et al. 1992). With respect to the fourth method, the extract is incorporated in the culture medium and the resultant colony forming units (CFU) are determined. Other bioassays, such as flow cytofluorometric and bioluminescent methods are not widely used because they require specified equipment and further evaluation for reproducibility and standardization (Balouiri et al. 2016). For many details, the above assessment techniques were reviewed by Balouiri et al. (2016).

3. Aspergillus

Aspergillus (Trichocomaceae) is a genus of ascomycetous fungi that grows in various environments. It has often been isolated from various environments, such as soil (Furtado et al. 2002; El-Aasar 2006; Cai et al. 2011; Amina et al. 2017; Hassan and Bakhiet 2017), various host plant tissues, as endophytic fungi (Kusari et al. 2009; Li et al. 2012; Monggoot et al. 2018), and aquatic environments (Nguyen et al. 2007; Qiao et al. 2010; Fukuda et al. 2014; Li et al. 2018). Aspergillus represents a large diverse genus, containing about 180 filamentous fungal species of substantial pharmaceutical and commercial values (Lubertozzi and Keasling 2009; Ibrahim et al. 2015a). Aspergillus is defined as a group of conidial fungi – that is, fungi in an asexual state. Some of them, however, are known to have a teleomorph (sexual state) in the Ascomycota, so with DNA evidence forthcoming, members of the genus Aspergillus can be considered members of the Ascomycota (Peterson 2008). Aspergillus is one of the major contributors to the secondary metabolites of fungal origin (Ibrahim et al. 2015b). It is well-known for its production of mycotoxins, such as aflatoxin, ochratoxin, gliotoxin, fumagillin, helvolic acid (fumigacin), fumitremorgin A, and asphemolysin (Wilson 1966; Bhetariya et al. 2011). These mycotoxins are capable of causing mycotoxicoses in animals and humans. In contrast, Aspergillus is currently expanding its application in various fields of medicine and pharmaceuticals. Many compounds, with antifungals, e.g., 3′-(3-Methylbutyl)-butyrolactone II (Cazar et al. 2005), antivirals, e.g., aspergillipeptides and asteltoxins (Tian et al. 2015; Ma et al. 2017a), antiprotozoal, e.g., (22E,24R)-stigmasta-5,7,22-trien-3-β-ol and stigmast-4-ene-3-one (Ibrahim et al. 2015b), antioxidant, e.g., 2-hydroxycircumdatin C (Cui et al. 2009), antidiabetic, e.g., isoaspulvinone E and aspulvinone E (Dewi et al. 2015), anticancer, e.g., [4-(2-methoxyphenyl)-1-piperazinyl](1-methyl-1H-indol-3-yl)-methanone (He et al. 2012), lipases (Yadav et al. 2000), α-amylases (Saranraj and Stella 2013), probiotics (Lee et al. 2006), and statins (Alberts et al. 1980) are all derived from Aspergillus.

3.1. Antibacterial metabolites from terrestrial Aspergillus spp

Many species of Aspergillus are active producers of many products of industrial and pharmaceutical importance (Mehta et al. 2017; Wang et al. 2015). Recently, a growing number of Aspergillus spp. fungi, have been reported to produce novel bioactive compounds, such as butenolide derivatives as anti-inflammatory agents (Liu et al. 2018), aurasperone H as anticancer (Li et al. 2016), asperchondols A and B as antibacterials (Liu et al. 2017), aspergivones A and B with anticancer and antibacterial activities (Ma et al. 2017b), and aspochalasin B and D as antibacterials (Ratnaweera et al. 2016). In this section, we discuss bioactive metabolites of Aspergillus spp., isolated from terrestrial environments, that shown antibacterial activities and could provide further cues for clinical trials. Table 1 summarises antibacterial findings reported on the preclinical antibacterial activity of the compounds and extracts from Aspergillus spp.

Table 1.

Antibacterials derived from terrestrial Aspergillus spp.

Fungus Antibacterial(s) Susceptible bacteria (MIC, IZD, or IC50) Reference
A. fumigatus Helvolic acid Gram-positive bacteria (Chain et al. 1943)
A. giganteus (Wehm) Claviformin (patulin) Gram-positive and Gram-negative bacteria (Florey et al. 1944)
A. fumigatus Aspergillin Mycobacterium tuberculosis (Soltys 1944)
A. niger (YWA), A. nidulans, A. oryzae (TP), and A. flavipes Culture filtrate Gram-positive and Gram-negative bacteria (Foster and Karow 1945)
Aspergillus spp. Culture filtrate Bacterium coli, S. aureus, and Pseudomonas pyocyanea (Wilkins and Harris 1945)
Aspergillus spp. Culture filtrate S. aureus and Salmonella typhi (Brian and Hemming 1947)
A. fumigatus Fumagillin Gram-positive and Gram-negative bacteria (Hanson and Eble 1949)
A. caespitosus 5,6-dihydro-5(S)-acetoxy-6(S)-1,2-trans-epoxypropyl)-2H-pyran-2-one, 5,6-dihydro-5(S)-acetoxy-6(S)-(1,2-trans propenyl)-2H-pyran-2-one, and 5,6-dihydro-5(R)-acetoxy-6(S)-(1,2-trans-epoxy-propyl)-H-pyran-2-one Salmonella paratyphi A (MIC = 50, 50, and 100 μg ml−1, respectively) (Mizuba et al. 1975)
A. terreus var. aureus Dihydrogeodin Bacillus subtilis (IFO-3513) (MIC = 6.25 μg ml−1) (Inamori et al. 1983)
A. quadrilineatus Petroleum ether extract of mycelia S. aureus and B. Subtilis (IZDs= 18 and 20 mm, respectively) (Irobi et al. 2000)
A. ochraceus (CL41582) CJ-17,665 S. aureus (MDRSA), S. pyogenes, and E. faecalis (MIC = 12.5, 12.5, and 25 μg ml−1, respectively) (Sugie et al. 2001)
A. fumigatus  Chloroform extract of mycelia S. aureus and M. luteus (IZDs = 20.67 and 39.33 mm, respectively) (Furtado et al. 2002)
A. niger (IFB-E003) Rubrofusarin B, fonsecinone A, asperpyrone B, and aurasperone A B. subtilis, E. coli, and P. fluorescence (MICs = 1.9-31.2 μg ml−1) (Song et al. 2004)
Aspergillus sp. (CY 725) Helvolic acid, monomethylsulochrin, ergosterol, and 3β-hydroxy-5α,8α-epidioxy-ergosta-6,22-diene Helicobacter pylori (Li et al. 2005)
Aspergillus spp. Ethyl acetate extract of mycelia Gram-positive and Gram-negative bacteria (IZDs = 0-15.2 mm) (Maria et al. 2005)
A. terreus var. terreus Terreic acid and Butyrolactone I Erwinia carotovora (IC50 = 5.1 and 12.5 μg ml−1, by terreic acid and butyrolactone I, respectively), B. subtilis and Micrococcus luteus (IZDs = 35 and 8 mm, respectively, by terreic acid), and Bacillus brevis, B. subtilis, and Enterobacter dissolvens (IZDs = of 30, 21, and 17 mm, respectively, by butyrolactone I) (Cazar et al. 2005)
A. flavus, A. glaucus, A. oryzae, A. parasiticus, and A. tamirii Kojic acid Gram-positive and Gram-negative bacteria (MICs = 176–285 μg ml−1) (El-Aasar 2006)
A. niger (FKI-2342) Tesyuic acid C B. subtilis (IZD= 10 mm) (Hasegawa et al. 2007)
A. awamori (F12) Emodin S. aureus and B. subtilis (MICs = 16 and 32 μg ml−1, respectively) (Chang et al. 2010). 
Aspergillus sp. Ethyl acetate extract of mycelia and culture filtrate Mycelial extract: (E. coli, K. pneumoniae, S. aureus, and P. aeruginosa; IZDs = 8.6–12 mm)
Culture broth: (P. aeruginosa and K. pneumoniae; IZDs = 13 and 15 mm)		 (Prabavathy and Nachiyar 2012).
A. fumigatus Ethyl acetate extract of mycelia B. subtilis, E. coli, K. pneumoniae, Shigella flexneri, and S. aureus (IZDs = 16, 18, 20, 11, and 16 mm, respectively) (Ruma et al. 2013)
Aspergillus sp. (EJC08) Fumigaclavine C and pseurotin A Fumigaclavine C: (B. subtilis, E. coli, P. aeruginosa, and S. aureus (MICs = 7.81, 62.5, 31.25, and 15.62 μg ml−1, respectively)
Pseurotin A: (B. subtilis, E. coli, P. aeruginosa, and S. aureus (MICs = 15.6, 31.3, 31.3, and 15.6 μg ml−1, respectively)		 (Pinheiro et al. 2013)
A. niger Culture filtrate P. aeruginosa, S. aureus, S. epidermidis, and Bacillus sp. (IZDs = 15, 25, 30, and 32 mm, respectively) (Al-Shaibani et al. 2013)
Aspergillus sp. Ethyl acetate extract of mycelia Gram-positive and Gram-negative bacteria (IZDs = 0–21.7 mm) (Sadrati et al. 2013)
Aspergillus sp. (KJ-9) Dianhydro-aurasperone C, fonsecinone A, asperazine, rubrofusarin B, and (R)-3- hydroxybutanonitrile E. coli, B. subtilis, B. cereus, and S. aureus (MICs = 25–50 μM) (Xiao et al. 2014)
A. fumigatiaffinis Neosartorin S. aureus, B. subtilis, and most streptococci (MICs = 4–8 μg ml−1) (Ola et al. 2014)
Aspergillus sp. Ergosterol, cerevisterol, 5-hydroxymethylfuran-3-carboxylic acid, allantoin, trypacidin, and monomethylsulochrin Allantoin showed the most activity, with MIC of 1 μg ml−1 against S. aureus, P. aeruginosa, S. typhimurium, and 2 μg ml−1 against B. subtilis, Staphylococcus faecalis, and E. coli (Zhang et al. 2014).
A. terreus (SM-EF 3) Ethyl acetate extract of mycelia S. typhi, S. aureus, V. cholera, E. coli, K. pneumoniae, S. paratyphi, and Klebsiella oxytoca (IZDs = 11.6, 10.3, 10, 9.3, 9, 8.6, and 5.6 mm, respectively) (Kalyanasundaram et al. 2015)
A. flavus (SM-EF 2) Ethyl acetate extract of mycelia S. paratyphi, P. mirabilis, and S. aureus (IZDs = 7, 5.3, and 5.6 mm, respectively) (Kalyanasundaram et al. 2015)
Aspergillus sp. (IFB-YXS) Xanthoascin Clavibacter michiganense subsp. sepedonicus (MIC = 0.31 μg ml−1) (Zhang et al. 2015)
A. niger Ethyl acetate extract of mycelia S. aureus, B. subtilis, and E. coli (IZDs = 9, 15, and 7 mm, respectively) (Ratnaweera et al. 2015)
A. fumigatus (AF3-093A) Flavipin, chaetoglobosin A, and chaetoglobosin B S. aureus, MRSA, and M. tuberculosis (H37Ra) (Flewelling et al. 2015)
A. terreus (22E,24R)-stigmasta-5,7,22-trien-3-β-ol (38) MRSA (IC50 = 0.96 μg ml−1) (Ibrahim et al. 2015b)
A. persii (EML-HPB1-11) Penicillic acid Twelve phytopathogenic bacteria (MICs = 12.3–111.1 μg ml−1) (Nguyen et al. 2016)
A. awamori (WAIR120; LC032125) Emodin E. faecalis (AHR7) (MIC = 125 μg ml−1) (Ismaiel et al. 2016)
A. tubingensis Ethyl acetate extract of the culture filtrate B. subtilis, S. aureus, P. aeruginosa, P. vulgaris, S. flexneri, and K. pneumonia (IZDs = 20.3, 16.5, 18, 15.7, 13, and 15.6 mm, respectively) (Padhi et al. 2017)
A. tamarii (SRRC 108818S) Ethyl acetate extract of mycelia S. typhi (ATCC33458), S. aureus (ATCC6538), B. subtilis (ATCC6633), E. coli (ATCC25922) (IZDs = 15.5, 14.5, 14, and 23 mm, respectively) (Ogbole et al. 2017)
A. fumigatus Acetonitrile extract of the culture filtrate S. typhimurium, Listeria monocytogenes, and P. aeruginosa (IZDs = 8, 19, and 25 mm, respectively) (Hassan and Bakhiet 2017)
A. fumigatus and A. niger Ethyl acetate extract of mycelia Proteus mirabilis, S. aureus, K. pneumoniae, P. aeruginosa, B. subtilis, and P. fluorescense (IZDs of A. fumigatus = 9, 9, 6, 13, 8, and 6.5 mm, respectively, while IZDs of A. niger = 2–6 mm) (Akinyemi 2017)
A. flavus, A. fumigatus, and A. niger Ethyl acetate extract of the culture filtrate S. pneumoniae, S. aureus, E. coli, and P. aeruginosa
(highest activity was of A. fumigatus, with MICs of 250 μg ml−1)		 (Yahaya et al. 2017)
A. clavatonanicus (MJ31) Ethyl acetate extracts of the mycelia and culture filtrate B. subtilis, M. luteus, and S. aureus (MICs = 0.078, 0.156, and 0.312 mg ml−1, respectively) (Mishra et al. 2017)
A. niger (MTCC-961) Ethyl acetate extract of the culture filtrate Gram-positive and Gram-negative bacteria (IZDs = 11–18 mm) (Kalyani and Hemalatha 2017)
A. oryzae (DBM4336) Ethyl acetate and ethanolic extracts of mycelia Gram-positive and Gram-negative bacteria (IZDs = 1–10 mm by ethanolic) (Synytsya et al. 2017)
Aspergillus spp. Chloroform extract of the culture filtrate S. aureus (ATCC 25923), B. subtilis (ATCC 6633), and E. coli (ATCC 25922) (IZDs = 7–31.67 mm) (Amina et al. 2017)
A. sclerotiorum (PSU-RSPG178) Penicillic acid S. aureus and E. coli (MICs = 128 μg ml−1, for each) (Phainuphong et al. 2017)
A. niger Ethyl acetate extract of mycelia S. aureus (MTCC96), M. luteus (MTCC106), P. aeruginosa (MTCC326), E. faecalis (MTCC439), and P. mirabilis (MTCC1429) (IZDs = 15–23 mm) (Thorati and Mishra 2017)
Aspergillus sp. Ethyl acetate extract of the culture filtrate Gram-positive and Gram-negative bacteria (IZDs = 9.2–15.2 mm and MICs = 15.62–250 μg ml−1) (Monggoot et al. 2018).
A. nidulans (MA-143) Isoversicolorin C, isosecosterigmatocystin, glulisine, and versicolorin Highest activities were for isoversicolorin C against Vibrio alginolyticus and E. ictaluri (MICs = 1 and 4 μg ml−1, respectively) and for
Isosecosterigmatocystin against E. coli, M. luteus, V. alginolyticus, V. parahaemolyticus, and E. ictaluri (MICs = 1–8 μg ml−1)		 (Yang et al. 2018)
A. versicolor Bisabolane sesquiterpenoid derivatives E. carotovora subsp. carotovora (MICs = 15.2 to 85.2 μg ml−1 (Guo et al. 2018)
A. fumigatus (CBA2743) Unidentified fractions of the fermentation broth F4 fraction fraction had positive antimycobacterial activity (MIC = 256 μg ml−1) (Silva et al. 2018)
Open in a new tab

Wilkins and Harris (1942) examined 100 species of fungi for the production of bacteriostatic or bactericidal substances. About 40% of the Aspergillus strains yielded antibiotics. A. fumigatus mut. helvola yielded particularly active filtrates, apparently superior to the bacteriostatic substances produced by Penicillium. The tested bacteria were E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa. A year later, Chain et al. (1943) subsequently isolated a crystalline antibiotic against Gram-positive bacteria from Aspergillus filtrates, which was named helvolic acid (1), and the name being derived from the variety of A. fumigatus yielding the best product.

A penicillin-like substance was isolated from A. giganteus (Wehm) by Philpot (1943), which she named gigantic acid. Later, Florey et al. (1944) isolated the antibiotic claviformin (patulin) (2) from a solution produced by A. giganteus (Wehm). For many years, claviformin was originally used as an antibiotic against Gram-positive and Gram-negative bacteria, but due to its toxicity to humans and animals, it was reclassified as a mycotoxin during the 1960s (Bennett and Klich 2003).

In 1944, Soltys (1944) extracted a product from A. fumigatus called aspergillin (3). This product is inactive against staphylococci but inhibits the growth of Mycobacterium tuberculosis even when tested in high dilutions. He concluded that this antibacterial is nontoxic for experimental animals and is sufficiently stable to withstand boiling for one hour.

graphic file with name TMYC_A_1604576_UF0001_B.jpg

Open in a new tab

Fumagillin (4) is a compound first isolated in 1949 as an antiphage agent called as antibiotic H-3 (Hanson and Eble 1949). This compound was isolated from A. fumigatus (H-3), and subsequently it was found to have antibacterial property, and was named fumagillin (Eble and Hanson 1951). After its discovery, fumagillin was used to treat human intestinal amebiasis (Killough et al. 1952) and microsporidiosis caused by Enterocytozoon bieneusi (Conteas et al. 2000).

graphic file with name TMYC_A_1604576_UF0002_B.jpg

Open in a new tab

A. caespitosus (NRRL 5769), growing in broth containing small amounts of sitosterol, produced three metabolites, namely, 5,6-dihydro-5(S)-acetoxy-6(S)-1,2-trans-epoxypropyl)-2H-pyran-2-one (5), 5,6-dihydro-5(S)-acetoxy-6(S)-(1,2-trans propenyl)-2H-pyran-2-one (6), and 5,6-dihydro-5(R)-acetoxy-6(S)-(1,2-trans-epoxy-propyl)-H-pyran-2-one (7). These metabolites showed antibacterial activity against Salmonella paratyphi A, with MIC values of 50, 50, and 100 μg ml−1, respectively (Mizuba et al. 1975).

graphic file with name TMYC_A_1604576_UF0003_B.jpg

Open in a new tab

Dihydrogeodin (8) was isolated from the fungus A. terreus var. aureus and showed antibacterial activity against Bacillus subtilis (IFO-3513), with MIC value of 6.25 μg ml−1 (Inamori et al. 1983).

A compound, named as CJ-17,665 (9), was isolated from the fermentation broth of A. ochraceus (CL41582), which isolated from a soil sample collected in Venezuela. This compound showed inhibitory effect against multi-drug resistant S. aureus (MDRSA), S. pyogenes, and E. faecalis, with MIC values of 12.5, 12.5, and 25 μg ml−1, respectively (Sugie et al. 2001). The chemical structure of this compound contains a diketopiperazine and an indole N-oxide moiety.

graphic file with name TMYC_A_1604576_UF0004_B.jpg

Open in a new tab

The chloroform extracts of A. fumigatus, isolated from a soil sample collected in Pantanal, Brazil, showed antibacterial activity against S. aureus and M. luteus, with IZDs of 20.7 and 39.3 mm, respectively. The antibacterial activity detected for the chloroform extract of the culture broth incubated without the pool of bacteria was lower than that detected for the extract with the pool. Benzathin penicillin G was used as positive control, with IZDs of 33 and >40 mm for S. aureus and M. luteus, respectively. The active compounds were isolated from the broth of the culture grown in the presence of pooled bacteria and identified as 3,4-dimethoxyphenol (10) and 1,3,5-trimethoxybenzene (11) (Furtado et al. 2002).

graphic file with name TMYC_A_1604576_UF0005_B.jpg

Open in a new tab

Fractionation of the extract of A. niger (IFB-E003), an endophyte in Cyndon dactylon (Poaceae), led to isolation of naphtho-γ-pyrones: rubrofusarin B (12), fonsecinone A (13), asperpyrone B (14), and aurasperone A (15). The four compounds exhibited growth inhibitions against B. subtilis, E. coli, and P. fluorescence, with MICs ranging from 1.9 to 31.2 μg ml−1. Penicillin and amikacin sulphate were used as positive controls (MICs = 0.45–3.9 μg ml−1) (Song et al. 2004).

graphic file with name TMYC_A_1604576_UF0006_B.jpg

Open in a new tab

Aspergillus sp. (CY 725) was isolated from leaves of C. dactylon (Poaceae). Through a bioassay-guided fractionation of the ethyl acetate extract of this fungus, four secondary metabolites were isolated. These metabolites were identified as helvolic acid (1), monomethylsulochrin (16), ergosterol (17), and 3β-hydroxy-5α,8α-epidioxy-ergosta-6,22-diene (18). These compounds showed antibacterial activity against Helicobacter pylori, but helvolic acid was the most active, with MIC value of 8 μg ml−1 (Li et al. 2005).

graphic file with name TMYC_A_1604576_UF0007_B.jpg

Open in a new tab

The fungus A. terreus var. terreus isolated from an Ecuador soil sample was cultured in liquid and solid media and yielded metabolites, including terreic acid (19) and butyrolactone I (20). These metabolites were screened for their antibacterial activity using agar diffusion assay, at a concentration of 100 μg disc−1, and serial dilution technique using 96-well microtitre plates. Compounds 19 and 20 were active towards the phytopathogenic bacterium Erwinia carotovora, with IC50 of 5.1 and 12.5 μg ml−1, respectively, compared to streptomycin (IC50 = 1.9 μg ml−1). Compound 19 was also active against B. subtilis and Micrococcus luteus, with IZDs of 35 and 8 mm, respectively, compared to chloramphenicol (IZDs = 26 and 36 mm, respectively). Compound 20 also inhibited the growth of Bacillus brevis, B. subtilis, and Enterobacter dissolvens, with IZDs of 30, 21, and 17 mm, respectively, compared to chloramphenicol (IZDs = 25, 26, and 21 mm, respectively) (Cazar et al. 2005).

graphic file with name TMYC_A_1604576_UF0008_B.jpg

Open in a new tab

It is well known that kojic acid (21), produced by various fungi including Aspergillus spp., is reported to possess antibacterial activity (Wilkins and Harris 1942; Marwaha et al. 1994). In a study conducted by El-Aasar (2006), A. flavus, A. glaucus, A. oryzae, A. parasiticus, and A. tamirii, isolated from a soil, were cultured for kojic acid production. The antibacterial activity of this compound was tested against six bacterial pathogens including Gram-positive and Gram-negative bacteria. The results revealed that kojic acid has activity against all the tested bacteria, with MIC values of 176–285 μg ml−1. Ceftazidime (MIC = 14–34 μg ml−1) and nitrofurantoin (MIC = 65–105 μg ml−1) were used as positive controls.

Six alkylitaconic acids, designated tensyuic acids A to F, were isolated from the culture broth of A. niger (FKI-2342) isolated from a soil collected at Ooura Tensyudou, Nagasaki, Japan. Only tesyuic acid C (22) showed antibacterial activity against B. subtilis, with IZD of 10 mm, at a concentration of 50 μg disc−1 (Hasegawa et al. 2007).

Emodin (23) was purified and elucidated from the ethyl acetate extract of fermentation broth of the fungus A. awamori (F12), which isolated from rhizospheric soil of Rhizophora stylosa (Rhizophoraceae). Antibacterial evaluation of emodin showed activity against S. aureus and B. subtilis, with MIC values of 16 and 32 μg ml−1, respectively (Chang et al. 2010).

graphic file with name TMYC_A_1604576_UF0009_B.jpg

Open in a new tab

The alkaloids known as fumigaclavine C (24) and pseurotin A (25) were isolated from Aspergillus sp. (EJC08) of the plant Bauhinia guianensis (Fabaceae). Compound 24 showed antibacterial activity against B. subtilis, E. coli, P. aeruginosa, and S. aureus, with MIC values of 7.8, 62.5, 31.3, and 15.6 μg ml−1, respectively, while Compound 25 was active against B. subtilis, E. coli, P. aeruginosa, and S. aureus, with MIC values of 15.6, 31.3, 31.3, and 15.6 μg ml−1, respectively (Pinheiro et al. 2013).

graphic file with name TMYC_A_1604576_UF0010_B.jpg

Open in a new tab

Dianhydro-aurasperone C (26), fonsecinone A (11), asperazine (27), rubrofusarin B (12), and (R)-3- hydroxybutanonitrile (28) were isolated from the fungal endophyte Aspergillus sp. (KJ-9) obtained from the plant Melia azedarach (Meliaceae) and tested against four bacteria: E. coli, B. subtilis, B. cereus, and S. aureus. These compounds displayed weak to moderate antibacterial activities against some bacteria (MICs = 25–50 μM) and exhibited better activity against Gram-positive bacteria than Gram-negative bacteria. Fonsecinone A inhibited the growth of S. aureus and B. subtilis, with equal MIC values of 25 μM, but weaker than that of streptomycin sulphate (MIC = 12.5 μM) (Xiao et al. 2014)

graphic file with name TMYC_A_1604576_UF0011_B.jpg

Open in a new tab

.

Neosartorin (29) was isolated from the endophytic fungus A. fumigatiaffinis, which isolated from the plant Tribulus terrestris (Zygophyllaceae) collected in Uzbekistan. Compound 29 inhibited the growth of a broad spectrum of Gram-positive bacteria, while the tested Gram-negative species were not affected. MIC values from4 to 8 μg ml−1 were obtained for S. aureus, B. subtilis, and most streptococci and the growth of enterococci was inhibited at slightly higher concentrations (16–32 μg ml−1) (Ola et al. 2014).

graphic file with name TMYC_A_1604576_UF0012_B.jpg

Open in a new tab

Seven compounds, namely, ergosterol (17), cerevisterol (30), 5-hydroxymethylfuran-3-carboxylic acid (31), allantoin (32), trypacidin (33), and monomethylsulochrin (16) were isolated from the endophytic fungal strain Aspergillus sp. (ER15), which obtained from the roots of Eucommia ulmoides (Eucommiaceae). These compounds were tested against a panel of Gram-positive and Gram-negative bacteria. Among these compounds, compound 32 was the most active, with MIC values of 1 μg ml−1 against S. aureus, P. aeruginosa, S. typhimurium, and 2 μg ml−1 against B. subtilis, Staphylococcus faecalis, and E. coli (Zhang et al. 2014).

graphic file with name TMYC_A_1604576_UF0013_B.jpg

Open in a new tab

Zhang et al. (2015) also tested the antibacterial activity of phenolic compounds obtained from ethanol extract derived from the solid-substrate fermentation of Aspergillus sp. (IFB-YXS), an endophytic fungus residing in the leaves of Ginkgo biloba (Ginkgoaceae). Among the compounds, xanthoascin (34) significantly inhibited the growth of the phytopathogenic bacterium Clavibacter michiganense subsp. sepedonicus, with MIC value of 0.31 μg ml−1, which is more potent than the positive control streptomycin (MIC = 0.62 μg ml−1). The antibacterial mechanism of xanthoascin was attributed to change the cellular permeability of the phytopathogens, leading to the remarkable leakage of nucleic acids out of the cytomembrane.

graphic file with name TMYC_A_1604576_UF0014_B.jpg

Open in a new tab

The crude extract of A. fumigatus (AF3-093A), an endophyte of the brown alga Fucus vesiculosus (Fucaceae), displayed significant antibacterial activity in initial bioactivity screens. Bioassay-guided fractionation of the extract led to the isolation of flavipin (35), chaetoglobosin A (36), and chaetoglobosin B (37). These compounds inhibited the growth of S. aureus, MRSA, and M. tuberculosis (H37Ra) (Flewelling et al. 2015).

graphic file with name TMYC_A_1604576_UF0015_B.jpg

Open in a new tab

Eight compounds were isolated from the endophytic fungus A. terreus isolated from the roots of Carthamus lanatus (Asteraceae) (Ibrahim et al. 2015b). The compound (22E,24R)-stigmasta-5,7,22-trien-3-β-ol (38), a stigmasterol derivative, displayed a potent activity against MRSA with IC50 value of 0.96 μg ml−1, compared to ciprofloxacin (IC50 = 0.07 μg ml−1).

The seed-borne fungus A. persii (EML-HPB1-11), isolated from the seeds of barley (Poaceae), produced penicillic acid (3-methoxy-5-methyl-4-oxo-2,5-hexadienoic acid) (39), which tested against 12 phytopathogenic bacteria. All of the bacterial pathogens tested were highly inhibited by this compound, with MIC values of 12.3–111.1 μg ml−1 (Nguyen et al. 2016). Although penicillic acid has antibacterial activity, it is toxic to human cells and halogenated furanone has carcinogenic toxicity (Bjarnsholt and Givskov 2007).

graphic file with name TMYC_A_1604576_UF0016_B.jpg

Open in a new tab

In a study conducted by Ismaiel et al. (2016), emodin (23) was isolated from A. awamori (WAIR120; LC032125), which isolated from stored wheat grain sample obtained locally from a retail supermarket (Zagaig, Egypt). This compound showed antibacterial activity against E. faecalis (AHR7), with MIC of 125 μg ml−1. Emodin was found to induce morphogenic effects including swelling and elongation of bacterial cell as shown by light microscopy. In addition, cellular effects were also resulted, in which emodin caused considerable changes in the nature of cell membrane and submicroscopic structure of bacterial cell as shown by transmission electron microscopy.

Ethyl acetate extracts of the fungi A. flavus, A. fumigatus, and A. niger, isolated from the soil of Bayero University Kano, were investigated for their antibacterial activities by disc diffusion assay. The extracts showed inhibitory activity against S. pneumoniae, S. aureus, E. coli, and P. aeruginosa. Highest activity was observed from the metabolites of A. fumigatus on all the test bacteria, with MIC values of 250 μg ml−1. The chromatogram study reveals many bioactive compounds, such as oleic acid (40) and n-hexadecanoic acid (41) known to have antibacterial activity against range of bacteria (Yahaya et al. 2017).

graphic file with name TMYC_A_1604576_UF0017_B.jpg

Open in a new tab

Phainuphong et al. (2017) found that penicillic acid (39), isolated from the fungus A. sclerotiorum (PSU-RSPG178), obtained from a soil sample from Suratthani province, Thailand, has antibacterial activity against S. aureus and E. coli, with equal MIC values of 128 μg ml−1.

Many strains of Aspergillus sp. were isolated and cultured from the flowers of the ethnomedicinal plant Mitrephora wangii (Annonaceae). The extract of the strain Aspergillus sp. (MFLUCC16-0845) showed broad activity against many bacterial pathogens, including S. aureus (ATCC 25923), S. epidermidis (ATCC 12228), S. agalactiae (ATCC13813), Bacillus subtilis (ATCC 19659), B. cereus (ATCC 11778), E. coli (ATCC 25922), S. typhi (ATCC 14028), K. pneumoniae (ATCC 700603), P. aeruginosa (ATCC 27853), and S. flexneri (ATCC 12022), with IZDs and MICs values of 8.3–13.4 mm and 15.62–500 μg ml−1, respectively. Penicillin was used as a positive control and exhibited IZDs and MICs of 9.2–15.2 mm and 15.62–250 μg ml−1, respectively. The results of gas chromatography–mass spectrometry indicated to the presence of many fungal metabolites, but β-thujaplicin (42) was at high yield (Monggoot et al. 2018).

Four compounds, namely isoversicolorin C (43), isosecosterigmatocystin (44), glulisine (45), and versicolorin C (46) were isolated from the mangrove-derived endophytic fungus A. nidulans (MA-143), obtained from leaves of the plant R. stylosa. Using the microplate assay, these compounds were tested for antibacterial activities against three human pathogens (E. coli, M. luteus, and Vibrio vulnificus) and four aquatic bacteria (Edwardsiella ictaluri, Vibrio alginolyticus, V. anguillarum, and V. parahaemolyticus). Compound 43 showed potent antibacterial activity against V. alginolyticus and E. ictaluri, with MIC values of 1 and 4 μg ml−1, respectively, while compound 44 exhibited activity against E. coli, M. luteus, V. alginolyticus, V. parahaemolyticus, and E. ictaluri, with MIC values ranging from 1 to 8 μg ml−1. Chloramphenicol was used as a positive control and exhibited MIC values ranging from 0.5 to 8 μg ml−1 (Yang et al. 2018).

graphic file with name TMYC_A_1604576_UF0018_B.jpg

Open in a new tab

Twelve bisabolane sesquiterpenoid derivatives were isolated from the endophytic fungus A. versicolor, obtained from the leaves of Elaeocarpus decipiens (Elaeocarpaceae). The activity of these compounds were tested against the enterobacterial plant pathogen E. carotovora subsp. carotovora, and the results showed that all compounds displayed antibacterial activities, with MIC values ranging from 15.2 to 85.2 μg ml−1 (Guo et al. 2018).

Under specific culture conditions, the endophytic A. fumigatus (CBA2743), obtained from the plant Copaifera multijuga (Fabaceae), released metabolites into the fermentation broth. The fractions of the fermentation broth were obtained by different chromatographic techniques and tested against Mycobacterium smegmatis and M. tuberculosis. The results showed that F4 fraction had positive antimycobacterial activity, with MIC value of 256 μg ml−1 (Silva et al. 2018).

3.2. Antibacterial properties of crude extracts

In this section, we discuss the crude extracts having antibacterial activities from terrestrial Aspergillus spp. These extracts with their susceptible bacteria are listed in Table 1. In preparing enzyme concentrates from certain moulds, antibacterial activity was noted in extract from a number of species characterized by high proteolytic capacity. Thus, two strains of A. clavatus were able to synthesise and release bactericidal products, into the liquid media, which possessed antibacterial activities against S. aureus and other bacteria (Wiesner 1942). In a study conducted by Foster and Karow (1945), antibacterial substances present in culture filtrates of A. niger (YWA), A. nidulans, A. oryzae (TP), and A. flavipes are either identical with, or closely related to, authentic penicillin produced by Penicillium notatum. This was shown by solubility properties, thermostability, pH stability, antibacterial spectra against 18 different bacteria, destruction by the enzyme penicillinase, and (in one instance) by efficacy in protecting animals against a lethal bacterial infection.

Wilkins and Harris (1945) observed that Aspergillus spp. produced bacteriostatic substances against Bacterium coli, S. aureus, and Pseudomonas pyocyanea.

Brian and Hemming (1947) reported that the culture filtrates of different species of Aspergillus displayed antibacterial activity against S. aureus and Salmonella typhi.

Irobi et al. (2000) worked on A. quadrilineatus isolated from moldy Acha, a common cereal grown among the plateau state of Nigeria. They found that the petroleum ether defatted crude extract of this fungus has remarkable antibacterial activity against S. aureus and B. Subtilis, with IZDs of 18 and 20 mm, respectively at pH 6.4.

Antibacterial activity of crude and partially purified ethyl acetate extracts, derived from two species of endophytic fungus Aspergillus, was tested. These fungi were isolated from mangrove fern Acrostichum aureum and mangrove angiosperm associate, Acanthus ilicifolius of Nethravathi Mangrove, on the southwest coast of India. The results showed different activities against a panel of bacteria including Gram-negative and Gram-positive bacteria, with IZDs ranging from 0 to 15.2 mm (Maria et al. 2005).

The antibacterial activity of the mycelia extracts and crude culture broth of the endophytic fungus Aspergillus sp., isolated from the leaf samples of Justicia adathoda (Acanthaceae), was evaluated by agar well diffusion method against some bacterial strains. Crude mycelial extract inhibited all the strains significantly, with a mean strongest IZD of 12 mm against E. coli. Crude culture broth inhibited the strains of P. aeruginosa and Klebsiella pneumoniae alone and had a mean stronger IZD of 13 and 15 mm, respectively, than crude mycelial extract (Prabavathy and Nachiyar 2012).

The crude ethyl acetate extract of A. fumigatus, isolated from the plant Garcinia spp. (Clusiaceae), was screened for antibacterial activity. It showed antibacterial activities against B. subtilis, E. coli, K. pneumoniae, Shigella flexneri, and S. aureus, with IZDs of 16, 18, 20, 11, and 16 mm, respectively (Ruma et al. 2013).

Al-Shaibani et al. (2013) studied the inhibitory effect of the culture filtrate of A. niger, obtained from the inflamed eyes of patients against P. aeruginosa, S. aureus, S. epidermidis, and Bacillus sp., which isolated from patients of microbial keratitis, who attended to Ibn Al-Haetham Eye Teaching Hospital, Baghdad, Iraq. The results revealed that A. niger possessed inhibitory effect against P. aeruginosa, S. aureus, S. epidermidis, and Bacillus sp., with IZDs of 15, 25, 30, and 32 mm, respectively.

Aspergillus sp. was isolated from the roots and leaves of Triticum durum (Poaceae) collected from the Bordj Bou Arreridj region (Algeria). Antibacterial activity of the crude ethyl acetate extract of this fungus was evaluated using agar diffusion assay against 12 pathogenic bacteria. Except Enterobacter agglomerans, P. aeruginosa, and Citrobacter freundii, the results revealed inhibition activity against the tested bacteria, with IZDs of 11.3–21.7 mm, and the largest zone was 21.7 mm against E. coli (Sadrati et al. 2013).

Many endophytic fungi were isolated from the leaves and stems of the plants Suaeda maritima and S. monoica (Amaranthaceae). Among these fungi, A. terreus (SM-EF 3) and A. flavus (SM-EF 2) were isolated. The fungal culture of these fungi were extracted with ethyl acetate and used as crude extract for checking their antibacterial activities by well diffusion method. The extract of A. terreus showed antibacterial activity, with IZDs of 11.6, 10.3, 10, 9.3, 9, 8.6, and 5.6 mm against S. typhi, S. aureus, V. cholera, E. coli, K. pneumoniae, S. paratyphi, and Klebsiella oxytoca, respectively. The extract of A. flavus showed antibacterial activity against S. paratyphi, P. mirabilis, and S. aureus with IZDs of 7, 5.3, and 5.6 mm, respectively (Kalyanasundaram et al. 2015).

The crude extract of the endophytic fungus A. niger, isolated from the leaves of Opuntia dillenii (Cactaceae), was investigated for its antibacterial potential against five bacterial species. The fungal extract showed activity against S. aureus, B. subtilis, and E. coli, with IZDs of 9, 15, and 7 mm, respectively (Ratnaweera et al. 2015).

The crude extract obtained from endolichenic fungus A. tubingensis, isolated from surface-sterilised lichen thallus of Parmelia caperata (Parmeliaceae), was assayed against six clinically significant bacterial pathogens. The extract displayed considerable antibacterial activity against B. subtilis, S. aureus, P. aeruginosa, P. vulgaris, S. flexneri, and K. pneumonia, with IZDs of 20.3, 16.5, 18.0, 15.7, 13.0, and 15.6 mm, respectively (Padhi et al. 2017).

The endophytic fungus A. tamarii (SRRC 108818S), isolated from the mushroom Lycoperdon umbrinum (Agaricaceae), was investigated for its antibacterial activity. At a concentration of 200 mg ml−1, ethyl acetate extract of this fungus showed activity against S. typhi (ATCC33458), S. aureus (ATCC6538), B. subtilis (ATCC6633), and E. coli (ATCC25922), with IZDs of 15.5, 14.5, 14, and 23 mm, respectively. Gentamicin was used as a positive control with IZDs of 16–18 mm (Ogbole et al. 2017).

The ability of A. fumigatus, isolated from Sudanese indigenous soil, to produce antibacterial compounds was tested by Hassan and Bakhiet (2017). The crude extract (5%) of the fungus exerted activity against Salmonella typhimurium, Listeria monocytogenes, and P. aeruginosa, with IZDs of 8, 19, and 25 mm, respectively.

Using agar well diffusion method, the mycelial extracts of the fungal endophytes, A. fumigatus and A. niger, isolated from different medicinal plants, were investigated for antibacterial activity against some bacterial species. A. fumigatus showed inhibition, with IZDs of 9, 9, 6, 13, 8, and 6.5 mm against Proteus mirabilis, S. aureus, K. pneumoniae, P. aeruginosa, B. subtilis, and P. fluorescense, respectively, while A. niger showed lowest inhibition, with IZDs ranging from 2 to 6 mm. Tetracycline was used as a positive control, with IZDs ranging from 13 to 21 mm (Akinyemi 2017).

Mishra et al. (2017) observed that ethyl acetate extract of the endophytic fungus A. clavatonanicus (MJ31), isolated from roots of Mirabilis jalapa (Nyctaginaceae), displayed antibacterial potential against B. subtilis, M. luteus, and S. aureus, with MICs of 0.078, 0.156, and 0.312 mg ml−1, respectively.

At different concentrations, the fungal extract of A. niger (MTCC-961), obtained from Microbial Type Culture Collection, Chandigarh, India, was tested for its antibacterial activity against eight bacterial species by agar well diffusion method. The results displayed antibacterial activity, with IZDs ranging from 11 to 18 mm, at a concentration of 100 μg ml−1. It also observed that the activity was concentration dependent. Gentamicin was used as a positive control and exhibited IZDs ranging from 15 to 19 mm (Kalyani and Hemalatha 2017).

A. oryzae (DBM4336), obtained from the Department of Biochemistry and Microbiology (DBM), University of Chemistry and Technology (Prague, Czech Republic), was screened for its antibacterial activity. At different solvent extractions, the antibacterial properties of fungal extracts were screened against seven bacterial species by disc diffusion method. From the results of the study, it was observed that different solvents used for preparation of the mycelial extracts gave different degrees in inhibitory activity. For this, the ethanol extract was found to be active against all seven testing bacteria used, with IZDs ranging from 1 to 10 mm, while aqueous extract was found to be not active (Synytsya et al. 2017).

The extracts of different endophytic fungi, A. nomius, A. oryzae, A. niger, A. terrus, and A. nidulans, isolated from different tissues (leaf, stem, and root) of Calotropis procera (Apocynaceae), were evaluated for their antibacterial potential against nine bacterial strains. The tested extracts showed activity against all tested bacterial strains, with IZDs ranging from 10 to 17.3 mm and MICs ranging from 15.6 to 250 μg ml−1 (Rani et al. 2017).

Ten species of Aspergillus were isolated from soil samples obtained from two different Algerian regions namely: Laghouat and Teleghma. The ten species were identified as A. fumigatus, A. niveus, A. wentii, A. fumigatiaffinis, A. quadrilineatus, A. nidulans, A. terreus, A. flavus, A. sclerotiorum, and A. niger. Using disc diffusion method, the extracts of these fungi exerted activity against S. aureus (ATCC 25923), B. subtilis (ATCC 6633), and E. coli (ATCC 25922), with IZDs ranging from 7 to 31.7 mm, and the highest activity was by A. fumigatus against S. aureus, with IZD of 31.7 mm. The extracts of all species had no activity on P. aeroginosa (ATCC 9027), except the extracts of A. niveus and A. wentii, with IZDs 8 and 7 mm, respectively (Amina et al. 2017).

The ethyl acetate extract of A. niger isolated from the stilt roots of Rhizophora apiculata (Rhizophoraceae) along South Andaman coast, India, was assayed for bioactivity against five pathogenic bacterial strains: S. aureus (MTCC96), M. luteus (MTCC106), P. aeruginosa (MTCC326), E. faecalis (MTCC439), and P. mirabilis (MTCC1429) by disc diffusion method. Sensitivity of the strains varied from P. mirabilis, which was most sensitive followed by P. aeruginosa, M. leuteus, S. aureus, and E. faecalis in decreasing order, with IZDs ranged from 15 to 23 mm (Thorati and Mishra 2017).

Conclusions

The rapid development in antibiotic resistance in bacteria has generated an increased demand for the development of novel therapies to treat bacterial infections. The present review focuses on antibacterial activity of Aspergillus spp. isolated from terrestrial environment from all over the world. Aspergillus spp. show antibacterial activity against pathogenic bacteria. According to literature, isolated compounds and extracts from Aspergillus spp. exhibit higher antibacterial activity against Gram-positive than Gram-negative bacteria. While several compounds exhibited higher IZDs or MICs than an antibiotic, some of them, such as the compound CJ-17,665, exhibited good activity against multi-drug resistant S. aureus, which is one of the most important current public health problem. Therefore, Aspergillus spp. may provide metabolites that may help treat infectious diseases that have increased resistance to current antibiotics, and could provide alternative medical treatment.

Acknowledgments

The authors thank Prof. Mohamed Ibrahim Ali for the invitation to write this paper.

Disclosure statement

No potential conflict of interest was reported by the authors.

References

  1. Akinyemi A. 2017. Antimicrobial activities of secondary metabolites from fungal endophytes. IOSR J Pharm Biol Sci. 12(6):13–17. https://www.google.com/search?ei=bQWuXMqbDMSvkwWCgZi4BA&q=Antimicrobial+Activities+of+Secondary+Metabolites+From+Fungal+Endophytes+Akinyem&oq=Antimicrobial+Activities+of+Secondary+Metabolites+From+Fungal+Endophytes+Akinyem&gs_l=psy-ab.3...41706.47766..48946...1.0..0.496.2370.4-5......0....2j1..gws-wiz.p_bLnv54Veo [Google Scholar]
  2. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, et al. 1980. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl- coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA. 77(7):3957–3961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Al-Shaibani ABA, Al-Shakarchi FI, Ameen RS. 2013. Extraction and characterization of antibacterial compound from Aspergillus niger. J Al-Nahrain Univ/Sci. 16(4):167–174. [Google Scholar]
  4. Amina B, Sana G, Atef J, Laid D, Noreddine KC. 2017. Antibacterial activity of Aspergillus isolated from different Algerian ecosystems. Afr J Biotechnol. 16(32):1699–1704. [Google Scholar]
  5. Bala N, Aitken EA, Fechner N, Cusack A, Steadman KJ. 2011. Evaluation of antibacterial activity of Australian basidiomycetous macrofungi using a high-throughput 96-well plate assay. Pharm Biol. 49(5):492–500. [DOI] [PubMed] [Google Scholar]
  6. Balouiri M, Sadiki M, Ibnsouda SK. 2016. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 6(2):71–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bennett JW, Klich M. 2003. Mycotoxins. Microbiol Mol Biol Rev. 16:497–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bérdy J. 2005. Bioactive microbial metabolites. J Antibiot. 58(1):1–26. [DOI] [PubMed] [Google Scholar]
  9. Bhetariya PJ, Madan T, Basir SF, Varma A, Usha SP. 2011. Allergens/antigens, toxins and polyketides of important Aspergillus species. Indian J Clin Biochem. 26(2):104–119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bills GF, Stadler M. 2014. Editorial comment – discovery, distribution and biosynthesis of fungal secondary metabolites. Mycology. 5(3):99–101. [Google Scholar]
  11. Bjarnsholt T, Givskov M. 2007. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci. 362(1483):1213–1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brian PW, Hemming HG. 1947. Production of antifungal and antibacterial substances by fungi; preliminary examination of 166 strains of fungi imperfecti. J Gen Microbiol. 1(2):158–167. [DOI] [PubMed] [Google Scholar]
  13. Bugni TS, Ireland CM. 2004. Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat Prod Rep. 21(1):143–163. [DOI] [PubMed] [Google Scholar]
  14. Cai S, Sun S, Zhou H, Kong X, Zhu T, Li D, Gu Q. 2011. Prenylated polyhydroxy-p-terphenyls from Aspergillus taichungensis ZHN-7-07. J Nat Prod. 74(5):1106–1110. [DOI] [PubMed] [Google Scholar]
  15. Calvo AM, Wilson RA, Bok JW, Keller NP. 2002. Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev. 66(3):447–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cazar ME, Schmeda-Hirschmann G, Astudillo L. 2005. Antimicrobial butyrolactone I derivatives from the Ecuadorian soil fungus Aspergillus terreus Thorn. var terreus. World J Microbiol Biotechnol. 21(6–7):1067–1075. [Google Scholar]
  17. Chain E, Florey HW, Jennings MA, Williams TI. 1943. Helvolic acid, an antibiotic produced by Aspergillus fumigatus mut. helcola Yuill. Br J Exp Pathol. 24(3):108–119. [Google Scholar]
  18. Chang M, Wang J, Tian F, Zhang Q, Ye B. 2010. Antibacterial activity of secondary metabolites from Aspergillus awamori F12 isolated from rhizospheric soil of Rhizophora stylosa Griff. Acta Microbiol Sin. 50(10):1385–1391. [Article in Chinese]. [PubMed] [Google Scholar]
  19. CLSI 2012. Performance standards for antimicrobial disk susceptibility tests, approved standard. seventh ed. 950 West Valley Road (Suite 2500, Wayne, Pennsylvania 19087, USA): CLSI document M02-A11.Clinical and Laboratory Standards Institute. [Google Scholar]
  20. Clutterbuck PW, Oxford AE, Raistrick H, Smith G. 1932. Studies in the biochemistry of microorganisms XXIV. The metabolic products of Penicillium brevi-compactum. Biochem J. 26(5):1441–1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Conteas CN, Berlin OG, Ash LR, Pruthi JS. 2000. Therapy for human gastrointestinal microsporidiosis. Am J Trop Med Hyg. 63(3–4):121–127. [DOI] [PubMed] [Google Scholar]
  22. Craney A, Ahmed S, Nodwell J. 2013. Towards a new science of secondary metabolism. J Antibiot. 66(7):387–400. [DOI] [PubMed] [Google Scholar]
  23. Cui C, Li X, Li C, Sun H, Gao S, Wang B. 2009. Benzodiazepine alkaloids from marine-derived endophytic fungus Aspergillus ochraceus. Helv Chim Acta. 92(7):1366–1370. [Google Scholar]
  24. Dewi RT, Tachibana S, Fajriah S, Hanafi M. 2015. α-Glucosidase inhibitor compounds from Aspergillus terreus RCC1 and their antioxidant activity. Med Chem Res. 24(2):737–743. [Google Scholar]
  25. Eble TE, Hanson FR. 1951. Fumagillin, an antibiotic from Aspergillus fumigatus H-3. Antibiot Chemother. 1(1):54–58. [PubMed] [Google Scholar]
  26. El-Aasar SA. 2006. . Cultural conditions studies on kojic acid production by Aspergillus parasiticus. Int J Agri Biol. 8(4):468–473. [Google Scholar]
  27. Fleming A. 1929. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol. 10(3):226–236. [Google Scholar]
  28. Flewelling AJ, Bishop AI, Johnson JA, Gray CA. 2015. Polyketides from an endophytic Aspergillus fumigatus isolate inhibit the growth of Mycobacterium tuberculosis and MRSA. Nat Prod Commun. 10(10):1661. [PubMed] [Google Scholar]
  29. Florey HW, Jennings MA, Philpot FJ. 1944. Claviformin from Aspergillus giganteus Wehm. Nature. 153:139. [Google Scholar]
  30. Foster JW, Karow EO. 1945. Microbiological aspects of penicillin VIII. Penicillin from different fungi. J Bacteriol. 49(1):19–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fukuda T, Kurihara Y, Kanamoto A, Tomoda H. 2014. Terretonin G, a new sesterterpenoid antibiotic from marine-derived Aspergillus sp. OPMF00272. J Antibiot. 67(8):593–595. [DOI] [PubMed] [Google Scholar]
  32. Furtado NAJC, Said S, Ito IY, Bastos JK. 2002. The antimicrobial activity of Aspergillus fumigatus is enhanced by a pool of bacteria. Microbiol Res. 157(3):207–211. [DOI] [PubMed] [Google Scholar]
  33. Guo ZY, Tan MH, Liu CX, Lv MM, Deng ZS, Cao F, Zou K, Proksch P. 2018. Aspergoterpenins A-D: four new antimicrobial bisabolane sesquiterpenoid derivatives from an endophytic fungus Aspergillus versicolor. Molecules. 23(6):1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hanson FR, Eble TE. 1949. An antiphage agent isolated from Aspergillus sp. J Bacteriol. 58(4):527–529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hasegawa Y, Fukuda T, Hagimori K, Tomoda H, Omura S. 2007. Tensyuic acids, new antibiotics produced by Aspergillus niger FKI-2342. Chem Pharm Bull. 55(9):1338–1341. [DOI] [PubMed] [Google Scholar]
  36. Hassan SAA, Bakhiet SEA. 2017. Optimization of antibacterial compounds production by Aspergillus fumigatus isolated from Sudanese indigenous soil. Int Biol Biomed J. 3(4):203–208. [Google Scholar]
  37. He F, Sun Y, Liu K, Zhang X, Qian P, Wang Y, Qi S. 2012. Indole alkaloids from marine-derived fungus Aspergillus sydowii SCSIO 00305. J Antibiot. 65(2):109–111. [DOI] [PubMed] [Google Scholar]
  38. Horgan KA, Murphy RA. 2011. Pharmaceutical and chemical commodities from fungi In: Kavanagh K, editor. Fungi: biology and applications. UK: Wiley-Blackwell; p. 147–178. [Google Scholar]
  39. Ibrahim SRM, Elkhayat ES, Mohamed GA, Khedr AIM, Fouad MA, Kotb MHR, Ross SA. 2015b. Aspernolides F and G, new butyrolactones from the endophytic fungus Aspergillus terreus. Phytochem Lett. 14:84–90. [Google Scholar]
  40. Ibrahim SRM, Mohamed GA, Moharram AM, Youssef DTA. 2015a. Aegyptolidines A and B: new pyrrolidine alkaloids from the fungus Aspergillus aegyptiacus. Phytochem Lett. 12:90–93. [Google Scholar]
  41. Inamori Y, Kato Y, Kubo M, Kamiki T, Takemoto T, Nomoto K. 1983. Studies on metabolites produced by Aspergillus terreus var. aureus. I. Chemical structures and antimicrobial activities of metabolites isolated from culture broth. Chem Pharm Bull. 31(12):4543–4548. [DOI] [PubMed] [Google Scholar]
  42. Irobi ON, Gbodi TA, Moo-Young M, Anderson WA. 2000. Antibiotic activity of Aspergillus quadrilineatus extracts isolated from a Nigerian cereal. Pharm Biol. 38(1):57–60. [DOI] [PubMed] [Google Scholar]
  43. Ismaiel AA, Rabie GH, Abd El-Aal MA. 2016. Antimicrobial and morphogenic effects of emodin produced by Aspergillus awamori WAIR120. Biologia. 71(5):464–474. [Google Scholar]
  44. Jansen N, Ohlendorf B, Erhard A, Bruhn T, Bringmann G, Imhoff JF. 2013. Helicusin E, isochromophilone X and isochromophilone XI: new chloroazaphilones produced by the fungus Bartalinia robillardoides strain LF550. Mar Drugs. 11(3):800–816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kalyanasundaram I, Nagamuthu J, Muthukumaraswamy S. 2015. Antimicrobial activity of endophytic fungi isolated and identified from salt marsh plant in Vellar Estuary. J Microbiol Antimicrob. 7(2):13–20. [Google Scholar]
  46. Kalyani P, Hemalatha KPJ. 2017. In vitro antimicrobial potential of Aspergillus niger (MTCC-961). Int J Chemtech Res. 10(4):430–435. [Google Scholar]
  47. Kavanagh K. 2011. Fungal fermentations systems and products In: Kavanagh K, editor. Fungi: biology and applications. UK: Wiley-Blackwell; p. 125–146. [Google Scholar]
  48. Killough JH, Magill GB, Smith RC. 1952. The treatment of amebiasis with fumagillin. Science. 115(2977):71–72. [DOI] [PubMed] [Google Scholar]
  49. Kusari S, Lamshöft M, Spiteller M. 2009. Aspergillus fumigatus Fresenius, an endophytic fungus from Juniperus communis L. Horstmann as a novel source of the anticancer pro-drug deoxypodophyllotoxin. J Appl Microbiol. 107(3):1019–1030. [DOI] [PubMed] [Google Scholar]
  50. Lee KW, Lee SK, Lee BD. 2006. Aspergillus oryzae as probiotic in poultry—a review. Int J Poult Sci. 5(1):1–3. [Google Scholar]
  51. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 10(12 suppl):S122–S129. [DOI] [PubMed] [Google Scholar]
  52. Li DH, Han T, Guan LP, Bai J, Zhao N, Li ZL, Wu X, Hua HM. 2016. New naphthopyrones from marinederived fungus Aspergillus niger 2HL-M-8 and their in vitro antiproliferative activity. Nat prod Res. 30(10):1116–1122. [DOI] [PubMed] [Google Scholar]
  53. Li W, Luo D, Huang J, Wang L, Zhang F, Xi T, Liao J, Lu Y. 2018. Antibacterial constituents from Antarctic fungus, Aspergillus sydowii SP-1. Nat Prod Res. 32(6):662–667. [DOI] [PubMed] [Google Scholar]
  54. Li XJ, Zhang Q, Zhang AL, Gao JM. 2012. Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities. J Agric Food Chem. 60(13):3424–3431. [DOI] [PubMed] [Google Scholar]
  55. Li Y, Song YC, Liu JY, Ma YM, Tan RX. 2005. Anti-Helicobacter pylori substances from endophytic fungal cultures. World J Microbiol Biotechnol. 21(4):553–558. [Google Scholar]
  56. Liu M, Zhou Q, Wang J, Liu J, Qi C, Lai Y, Zhu H, Xue Y, Hu Z, Zhang Y. 2018. Anti-inflammatory butenolide derivatives from the coral-derived fungus Aspergillus terreus and structure revisions of aspernolides D and G, butyrolactone VI and 4′,8″-diacetoxy butyrolactone VI. RSC Adv. 8:13040–13047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Liu S, Dai H, Konuklugil B, Orfali RS, Lin WH, Kalscheuer R, Liu Z, Proksch P. 2017. Phenolic bisabolanes from the sponge-derived fungus Aspergillus sp. Phytochem Lett. 18:187–191. [Google Scholar]
  58. Lubertozzi D, Keasling JD. 2009. Developing Aspergillus as a host for heterologous expression. Biotechnol Adv. 27(1):53–75. [DOI] [PubMed] [Google Scholar]
  59. Ma J, Zhang XL, Wang Y, Zheng JY, Wang CY, Shao CL. 2017b. Aspergivones A and B, two new flavones isolated from a gorgonian-derived Aspergillus candidus fungus. Nat Prod Res. 31(1):32–36. [DOI] [PubMed] [Google Scholar]
  60. Ma X, Nong X, Ren Z, Wang J, Liang X, Wang L, Qi S. 2017a. Antiviral peptides from marine gorgonian-derived fungus Aspergillus sp. SCSIO 41501. Tetrahedron Lett. 58(12):1151–1155. [Google Scholar]
  61. Maria GL, Sridhar KR, Raviraja NS. 2005. Antimicrobial and enzyme activity of mangrove endophytic fungi of southwest coast of India. J Agr Technol. 1:67–80. [Google Scholar]
  62. Marwaha SS, Kaur J, Sodhi GS. 1994. Organomercury(II) complexes of kojic acid and maltol: synthesis, characterization, and biological studies. J Inorg Biochem. 54(1):67–74. [DOI] [PubMed] [Google Scholar]
  63. Mehta A, Bodh U, Gupta R. 2017. Fungal lipases: a review. J Biotechnol Res. 8:58–77. [Google Scholar]
  64. Mishra VK, Passari AK, Chandra P, Leo VV, Kumar B, Uthandi S, Thankappan S, Gupta VK, Singh BP. 2017. Determination and production of antimicrobial compounds by Aspergillus clavatonanicus strain MJ31, an endophytic fungus from Mirabilis jalapa L. using UPLC-ESI-MS/MS and TD-GC-MS analysis. PLoS One. 12(10):e0186234. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  65. Mizuba S, Lee K, Jiu J. 1975. Three antimicrobial metabolites from Aspergillus caespitosus. Can J Microbiol. 21(11):1781–1787. [DOI] [PubMed] [Google Scholar]
  66. Monggoot S, Pichaitam T, Tanapichatsakul C, Pripdeevech P. 2018. Antibacterial potential of secondary metabolites produced by Aspergillus sp., an endophyte of Mitrephora wangii. Arch Microbiol. 200(6):951–959. [DOI] [PubMed] [Google Scholar]
  67. Newton GGF, Abraham EP. 1955. Cephalosporin C, A new antibiotic containing sulphur and D-α-aminoadipic acid. Nature. 175(4456):548. [DOI] [PubMed] [Google Scholar]
  68. Ng TB, Cheung RCF, Wong JH, Bekhit AA, Bekhit AE. 2015. Antibacterial products of marine organisms. Appl Microbiol Biotechnol. 99(10):4145–4173. [DOI] [PubMed] [Google Scholar]
  69. Nguyen HP, Zhang D, Lee U, Kang JS, Choi HD, Son BW. 2007. Dehydroxychlorofusarielin B, an antibacterial polyoxygenated decalin derivative from the marine-derived fungus Aspergillus sp. J Nat Prod. 70(7):1188–1190. [DOI] [PubMed] [Google Scholar]
  70. Nguyen HT, Yu NH, Jeon SJ, Lee HW, Bae CH, Yeo JH, Lee HB, Kim IS, Park HW, Kim JC. 2016. Antibacterial activities of penicillic acid isolated from Aspergillus persii against various plant pathogenic bacteria. Lett Appl Microbiol. 62(6):488–493. [DOI] [PubMed] [Google Scholar]
  71. Ogbole OO, Adebayo-Tayo BC, Salawu KM, Okoli VC. 2017. Molecular identification and antimicrobial activity of endophytic fungi Aspergillus tamarii (trichomaceae). Nig J Pharm Sci. 16(1):41–48. [Google Scholar]
  72. Ola ARB, Debbab A, Aly AH, Mandi A, Zerfass I, Hamacher A, Kassack MU, Brötz-Oesterhelt H, Kurtan T, Proksch P. 2014. Absolute configuration and antibiotic activity of neosartorin from the endophytic fungus Aspergillus fumigatiaffinis. Tetrahedron Lett. 55(5):1020–1023. [Google Scholar]
  73. Padhi S, Das D, Panja S, Tayung K. 2017. Molecular characterization and antimicrobial activity of an endolichenic fungus, Aspergillus sp. isolated from Parmelia caperata of Similipal Biosphere Reserve, India. Interdiscip Sci Comput Life Sci. 9(2):237–246. [DOI] [PubMed] [Google Scholar]
  74. Perrone G, Susca A, Cozzi G, Ehrlich K, Varga J, Frisvad JC, Meijer M, Noonim P, Mahakarnchanakul W, Samson RA. 2007. Biodiversity of Aspergillus species in some important agricultural products. Stud Mycol. 59:53–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Peterson SW. 2008. Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia. 100(2):205–226. [DOI] [PubMed] [Google Scholar]
  76. Phainuphong P, Rukachaisirikul V, Tadpetch K, Sukpondma Y, Saithong S, Phongpaichit S, Preedanon S, Sakayaroj J. 2017. γ-Butenolide and furanone derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178. Phytochemistry. 137:165–173. [DOI] [PubMed] [Google Scholar]
  77. Philpot FJ. 1943. A penicillin-like substance from Aspergillus giganteus Wehm. Nature. 152:725. [Google Scholar]
  78. Pinheiro EA, Carvalho JM, Dos Santos DC, FeitosaAde O, Marinho PS, Guilhon GM, de Souza AD, Da Silva FM, Marinho AM. 2013. Antibacterial activity of alkaloids produced by endophytic fungus Aspergillus sp. EJC08 isolated from medical plant Bauhinia guianensis. Nat Prod Res. 27(18):1633–1638. [DOI] [PubMed] [Google Scholar]
  79. Prabavathy D, Nachiyar CV. 2012. Study on the antimicrobial activity of Aspergillus sp. isolated from Justicia adathoda. Indian J Sci Technol. 5(9):3317–3320. [Google Scholar]
  80. Qiao M, Ji N, Liu X, Li K, Zhu Q, Xue Q. 2010. Indoloditerpenes from an algicolous isolate of Aspergillus oryzae. Bioorg Med Chem Lett. 20(19):5677–5680. [DOI] [PubMed] [Google Scholar]
  81. Rani R, Sharma D, Chaturvedi M, Yadav JP. 2017. Antibacterial activity of twenty different endophytic fungi isolated from Calotropis procera and time kill assay. Clin Microbiol. 6(3):280. [Google Scholar]
  82. Ratnaweera PB, de Silva ED, Williams DE, Andersen RJ. 2015. Antimicrobial activities of endophytic fungi obtained from the arid zone invasive plant Opuntia dillenii and the isolation of equisetin, from endophytic Fusarium sp. BMC Complement Altern Med. 15:220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Ratnaweera PB, Williams DE, de Silva ED, Andersen RJ. 2016. Antibacterial metabolites from the Sri Lankan demosponge-derived fungus, Aspergillus flavipes. Curr Sci. 111(9):1473–1479. [Google Scholar]
  84. Ruma K, Sunil K, Prakash HS. 2013. Antioxidant, anti-inflammatory, antimicrobial and cytotoxic properties of fungal endophytes from Garcinia species. Int J Pharm Pharm Sci. 5(Suppl.3):889–897. [Google Scholar]
  85. Sadrati N, Daoud H, Zerroug A, Dahamna S, Bouharati S. 2013. Screening of antimicrobial and antioxidant secondary metabolites from endophytic fungi isolated from wheat (Triticum durum). J Plant Prot Res. 53(2):128–136. [Google Scholar]
  86. Saranraj P, Stella D. 2013. Fungal amylase—a review. Int J Microbiol Res. 4(2):203–211. [Google Scholar]
  87. Silva EMS, Da Silva IR, Ogusku MM, Carvalho CM, Maki CS, Rudi Procópio REL. 2018. Metabolites from endophytic Aspergillus fumigatus and their in vitro effect against the causal agent of tuberculosis. Acta Amaz. 48(1):63–69. [Google Scholar]
  88. Soltys MA. 1944. Antibiotic action of Aspergillus fumigatus against Mycobacterium tuberculosis. Nature. 154:550–551. [Google Scholar]
  89. Song YC, Li H, Ye YH, Shan CY, Yang YM, Tan RX. 2004. Endophytic naphthopyrone metabolites are co-inhibitors of xanthine oxidase, SW1116 cell and some microbial growths. FEMS Microbiol Lett. 241(1):67–72. [DOI] [PubMed] [Google Scholar]
  90. Soothill JS, Ward R, Girling AJ. 1992. The IC50: an exactly defined measure of antibiotic sensitivity. J Antimicrob Chemother. 29(2):137–139. [DOI] [PubMed] [Google Scholar]
  91. Sugie Y, Hirai H, Inagaki T, Ishiguro M, Kim YJ, Kojima Y, Sakakibara T, Sakemi S, Sugiura A, Suzuki Y, et al. 2001. A new antibiotic CJ-17,665 from Aspergillus ochraceus. J Antibiot. 54(11):911–916. [DOI] [PubMed] [Google Scholar]
  92. Synytsya A, Monkai J, Bleha R, Macurkova A, Ruml T, Ahn J, Chukeatirote E. 2017. Antimicrobial activity of crude extracts prepared from fungal mycelia. Asian Pac J Trop Biomed. 7(3):257–261. [Google Scholar]
  93. Thorati M, Mishra JK. 2017. Antibacterial activity of crude extract from Aspergillus niger isolated from the stilt roots of Rhizophora apiculata along South Andaman coast, India. J Pharmacogn Phytochem. 6(5):1635–1638. [Google Scholar]
  94. Tian YQ, Lin XP, Wang Z, Zhou XF, Qin XC, Kaliyaperumal K, Zhang TY, Tu ZC, Liu Y. 2015. Asteltoxins with antiviral activities from the marine sponge-derived fungus Aspergillus sp. SCSIO XWS02F40. Molecules. 21(1):E34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Valgas C, de Souza SM, Smânia EFA, Zhou XF, Qin XC, Kaliyaperumal K, Zhang TY, Tu ZC, Liu Y. 2007. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol. 38(2):369–380. [Google Scholar]
  96. Wang W, Liao Y, Tang C, Huang X, Luo Z, Chen J, Cai P. 2017. Cytotoxic and antibacterial compounds from the coral-derived fungus Aspergillus tritici SP2-8-1. Mar Drugs. 15(11):348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Wang Y, Xue Y, Liu C. 2015. A brief review of bioactive metabolites derived from deep-sea fungi. Mar Drugs. 13(8):4594–4616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Wiesner BP. 1942. Bactericidal effect of Aspergillus clacatus. Nature. 149:356–357. [Google Scholar]
  99. Wilkins WH, Harris GCM. 1942. Investigation into the production of bacteriostatic substances by fungi. I. Preliminary examination of 100 fungal species. Br J Exp Pathol. 23(4):166–169. [Google Scholar]
  100. Wilkins WH, Harris GCM. 1945. Investigation into the production of bacteriostatic substances by fungi: V. Preliminary examination of the third 100 fungi with special reference to strain variation among species of Aspergillus. Trans Brit Mycol Soc. 27(3–4):113–118. [Google Scholar]
  101. Wilson BJ. 1966. Toxins other than aflatoxins produced by Aspergillus flavus. Bacteriol Rev. 30(2):478–484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Wo G, Jahnsen S, Lorck H, Roholt K, Tybring L. 1962. Fusidic acid, a new antibiotic. Nature. 193:987. [DOI] [PubMed] [Google Scholar]
  103. Xiao J, Zhang Q, Gao YQ, Shi XW, Gao JM. 2014. Antifungal and antibacterial metabolites from an endophytic Aspergillus sp. associated with Melia azedarach. Nat Prod Res. 28(17):1388–1392. [DOI] [PubMed] [Google Scholar]
  104. Xu W, Li G, Huang X, Luo Z. 2015. Fungal diversity study in the deep sea sediments of three oceans by culture-dependent approach. J Appl Oceanogr. 34:103–110. (In Chinese). [Google Scholar]
  105. Yadav RP, Agarwal P, Upadhyay SN. 2000. Microbial lipases: tool for drug discovery. J Sci Ind Res. 59:977–987. [Google Scholar]
  106. Yahaya S, Idris B, Yusuf I, Rabiu MK. 2017. Screening and identification of antibacterial agents produced by Aspergillus species from the soil of Bayero University Kano. Bayero J Pure Appl Sci. 10(1):498–502. [Google Scholar]
  107. Yang SQ, Li XM, Xu GM, Li X, An CY, Wang BG. 2018. Antibacterial anthraquinone derivatives isolated from a mangrove-derived endophytic fungus Aspergillus nidulans by ethanol stress strategy. J Antibiot. 71(9):778–784. [DOI] [PubMed] [Google Scholar]
  108. Zhang H, Liu R, Zhou F, Wang R, Liu X, Zhang H. 2014. Antimicrobial metabolites from the endophytic fungus Aspergillus sp. of Eucommia ulmoides. Chem Nat Compd. 50(3):526–528. [Google Scholar]
  109. Zhang W, Wei W, Shi J, Chen C, Zhao G, Jiao R, Tan R. 2015. Natural phenolic metabolites from endophytic Aspergillus sp. IFB-YXS with antimicrobial activity. Bioorg Med Chem Lett. 25(13):2698–2701. [DOI] [PubMed] [Google Scholar]

Articles from Mycology are provided here courtesy of Taylor & Francis

RESOURCES